Regeneron Pharmaceuticals (REGN) Q1 2016 Earnings

9FebConfirmed
Q2 2015
Q3 2015
Q4 2015
Q1 2016
2.66
2.93
3.2
3.47

Details

Expected EPS
3.33
Actual EPS
2.83
Surprise EPS
-0.5
Surprise Percent
+15.02%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 2.83 per share for Q1 2016.

0 Comments

Share your thoughts